Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
1.710
+0.010 (0.59%)
At close: Jun 26, 2026, 4:00 PM EDT
1.740
+0.030 (1.75%)
After-hours: Jun 26, 2026, 7:59 PM EDT
BDTX Employees
Black Diamond Therapeutics had 21 employees as of December 31, 2025. The number of employees decreased by 3 or -12.50% compared to the previous year.
Employees
21
Change (1Y)
-3
Growth (1Y)
-12.50%
Revenue / Employee
n/a
Profits / Employee
-$2,057,667
Market Cap
97.99M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cibus | 118 |
| Alps Group | 93 |
| Pelthos Therapeutics | 92 |
| Vivani Medical | 42 |
| Biomea Fusion | 40 |
| Cue Biopharma | 29 |
| Cognition Therapeutics | 14 |
| Atara Biotherapeutics | 13 |
BDTX News
- 1 day ago - Black Diamond Therapeutics Transcript: AGM 2026 - Transcripts
- 24 days ago - Black Diamond Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 5 weeks ago - Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Black Diamond Therapeutics Transcript: Study result - Transcripts
- 5 weeks ago - Black Diamond Therapeutics Press release: Study result - Filings
- 5 weeks ago - Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations - GlobeNewsWire
- 5 weeks ago - Black Diamond Therapeutics Slides: Corporate presentation - Filings
- 5 weeks ago - Black Diamond Therapeutics to Host Webcast for Investors Highlighting Updated Results from Phase 2 Trial of Silevertinib in 1L EGFRm NSCLC - GlobeNewsWire